WebCompany Description: Biogen is a global biopharmaceutical company focused on discovering, developing and delivering worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen's marketed products include TECFIDERA, VUMERITY, AVONEX, … WebBiogen is committed to meeting its global transparency reporting requirements. We record all transfers of value to health care professionals and organizations and report pursuant to the applicable local codes and laws. We support independent initiatives through advocacy organizations and independent medical education.
Presentations Investor Relations Biogen
WebApr 4, 2024 · Biogen Appoints Adam Keeney as Head of Corporate Development. Published: April 4, 2024 at 7:30 a.m. ET. The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE ... WebThe company’s website provides answers to frequently asked questions and clinical resources for medical/healthcare professionals. That said, there is a personal assistance component in the form of phone and e-mail support. Key Activities. Biogen’s business model entails designing, developing, and manufacturing its products. hdhp health coverage
Multiple Sclerosis Biogen
WebMar 16, 2024 · The average employee at Biogen makes $92,036 per year. In comparison, some of its highest paying competitors, like Gilead Sciences, Genentech, and QuintilesIMS, pay $99,828, $97,473, and $95,481, respectively. A large health care company with 9,100 employees and an annual revenue of $10.2B, Biogen is headquartered in Cambridge, MA. WebApr 13, 2024 · The company has a market cap of $41.29 billion, a P/E ratio of 13.65, a PEG ratio of 2.46 and a beta of 0.19. Biogen Inc. has a 12-month low of $187.16 and a 12-month high of $311.88. Biogen (NASDAQ:BIIB - Get Rating) last issued its quarterly earnings data on Wednesday, February 15th. The biotechnology company reported $4.05 earnings … WebMultiple sclerosis (MS) is a complex, heterogeneous, chronic disease that requires individualized treatment throughout a patient’s life. The disease involves the central nervous system and disrupts the flow of information within the brain and between the brain and body, signaling unpredictable symptoms. 1 hdhp highmark